RESUMO-O termo milho safrinha é empregado para o cultivo de milho de sequeiro semeado de janeiro a abril, após a colheita da cultura de verão. Para caracterizar os sistemas de produção de altas produtividades de milho safrinha foram coletados dados referentes a 1.138 lavouras que obtiveram produtividade acima de 5.000 kg ha-1 , nos estados da região Centro-Oeste, em São Paulo e no Paraná. Embora tenham sido constatados rendimentos superiores a 8.000 kg ha-1 em todos os estados produtores de milho safrinha, a maior frequencia é de lavouras com rendimentos entre 5.000 e 7.000 kg ha-1. Nessas lavouras, predominou o plantio de híbridos simples e de ciclo precoce, no sistema plantio direto, com o milho sendo implantado no mês de fevereiro e cultivado geralmente após a soja. Em São Paulo e no Paraná, predominam o uso do espaçamento convencional, enquanto que nos estados da região Centro-Oeste a utilização de espaçamento reduzido é maior, especialmente em Goiás. A população de plantas variou de 45 a 65 mil plantas por hectare, com maior frequência no uso de 50 a 55 mil plantas por hectare. Cerca de 90% das lavouras receberam tratamento químico com fungicidas para o controle de doenças. O número de aplicações de inseticidas variou de zero até quatro aplicações, sendo mais frequente duas e três aplicações. Palavras-chave: Zea mays, sistema de produção, população de plantas, espaçamento entre fileiras, época de semeadura.

No abstract

The development of alternative approaches for safety and efficacy testing that avoid the use of animals is a worldwide trend, which relies on the improvement of current models and tools so that they better reproduce human biology. Human skin from elective plastic surgery is a promising experimental model to test the effects of topically applied products. As the structure of native skin is maintained, including cell population (keratinocytes, melanocytes, Langerhans cells and fibroblasts) and dermal matrix (containing collagen, elastin, glycosaminoglycans, etc.), it most closely matches the effects of substances on in vivo human skin. In this review, we present a collection of results that our group has generated over the last years, involving the use of human skin and scalp explants, demonstrating the feasibility of this model. The development of a test system with ex vivo skin explants, of standard size and thickness, and cultured at the air–liquid interface, can provide an important tool for understanding the mechanisms involved in several cutaneous disorders.

No abstract

Quercetin has potent antioxidant action and a hepatoprotective role. The aim of this study was to evaluate the hepatoprotective action of quercetin pretreatment in paracetamol-induced liver damage (PILD) and structural injury resulting from partial hepatectomy (PH

Reference evapotranspiration (ETo) is a fundamental parameter for hydrological studies and irrigation management. The Penman-Monteith method is the standard to estimate ETo and requires several meteorological elements. In developing countries, the number of weather stations is insufficient. Thus, free products of remote sensing with evapotranspiration information must be used for this purpose. In this context, the objective of this study was to estimate monthly ETo from potential evapotranspiration (PET) made available by MOD16 product. In this study, the monthly ETo estimated by Penman-Monteith method was considered as the standard. For this, data from 265 weather station of the National Institute of Meteorology (INMET), spread all over the Brazilian territory, were acquired for the period from 2000 to 2014 (15 years). For these months, monthly PET values from MOD16 product for all Brazil were also downloaded. By using machine learning algorithms and information from WorldClim as covariates, ETo was estimated through images from the MOD16 product. To perform the modeling of ETo, eight regression algorithms were tested: multiple linear regression; random forest; cubist; partial least squares; principal components regression; adaptive forward-backward greedy; generalized boosted regression and generalized linear model by likelihood-based boosting. Data from 2000 to 2012 (13 years) were used for training and data of 2013 and 2014 (2 years) were used to test the models. The PET made available by the MOD16 product showed higher values than those of ETo for different periods and climatic regions of Brazil. However, the MOD16 product showed good correlation with ETo, indicating that it can be used in ETo estimation. All models of machine learning were effective in improving the performance of the metrics evaluated. Cubist was the model that presented the best metrics for r2 (0.91), NSE (0.90) and nRMSE (8.54%) and should be preferred for ETo prediction. MOD16 product is recommended to be used to predict monthly ETo, which opens possibilities for its use in several other studies.

Capsiate treatment preceding hepatic surgery may compromise the initial period of postoperative recovery.

Chronic treatment of rats with N(omega)-nitro-L-arginine methyl ester (L-NAME), an inhibitor of nitric oxide (NO) biosynthesis, results in hypertension mediated partly by enhanced angiotensin-I-converting enzyme (ACE) activity. We examined the influence of L-NAME on rat liver morphology, on hepatic glycogen, cholesterol, and triglyceride content, and on the activities of the cytochrome P450 isoforms CYP1A1/2, CYP2B1/2, CYP2C11, and CYP2E1. Male Wistar rats were treated with L-NAME (20 mg/rat per day via drinking water) for 2, 4, and 8 weeks, and their livers were then removed for analysis. Enzymatic induction was produced by treating rats with phenobarbital (to induce CYP2B1/2), beta-naphthoflavone (to induce CYP1A1/2), or pyrazole (to induce CYP2E1). L-NAME significantly elevated blood pressure; this was reversed by concomitant treatment with enalapril (ACE inhibitor) or losartan (angiotensin II AT(1) receptor antagonist). L-NAME caused vascular hypertrophy in hepatic arteries, with perivascular and interstitial fibrosis involving collagen deposition. Hepatic glycogen content also significantly increased. L-NAME did not affect fasting glucose levels but significantly reduced insulin levels and increased the insulin sensitivity of rats, based on an intraperitoneal glucose tolerance test. Immunoblotting experiments indicated enhanced phosphorylation of protein kinase B and of glycogen synthase kinase 3. All these changes were reversed by concomitant treatment with enalapril or losartan. L-NAME had no effect on hepatic cholesterol or triglyceride content or on the basal or drug-induced activities and protein expression of the cytochrome P450 isoforms. Thus, the chronic inhibition of NO biosynthesis produced hepatic morphological alterations and changes in glycogen metabolism mediated by the renin-angiotensin system. The increase in hepatic glycogen content probably resulted from enhanced glycogen synthase activity following the inhibition of glycogen synthase kinase 3 by phosphorylation.